1
|
N-Phenacyldibromobenzimidazoles—Synthesis Optimization and Evaluation of Their Cytotoxic Activity. Molecules 2022; 27:molecules27144349. [PMID: 35889223 PMCID: PMC9315981 DOI: 10.3390/molecules27144349] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2022] [Revised: 06/27/2022] [Accepted: 07/05/2022] [Indexed: 02/01/2023] Open
Abstract
Antifungal N-phenacyl derivatives of 4,6- and 5,6-dibromobenzimidazoles are interesting substrates in the synthesis of new antimycotics. Unfortunately, their application is limited by the low synthesis yields and time-consuming separation procedure. In this paper, we present the optimization of the synthesis conditions and purification methods of N-phenacyldibromobenzimidazoles. The reactions were carried out in various base solvent-systems including K2CO3, NaH, KOH, t-BuOK, MeONa, NaHCO3, Et3N, Cs2CO3, DBU, DIPEA, or DABCO as a base, and MeCN, DMF, THF, DMSO, or dioxane as a solvent. The progress of the reaction was monitored using HPLC analysis. The best results were reached when the reactions were carried out in an NaHCO3–MeCN system at reflux for 24 h. Additionally, the cytotoxic activity of the synthesized compounds against MCF-7 (breast adenocarcinoma), A-549 (lung adenocarcinoma), CCRF-CEM (acute lymphoblastic leukemia), and MRC-5 (normal lung fibroblasts) was evaluated. We observed that the studied cell lines differed in sensitivity to the tested compounds with MCF-7 cells being the most sensitive, while A-549 cells were the least sensitive. Moreover, the cytotoxicity of the tested derivatives towards CCRF-CEM cells increased with the number of chlorine or fluorine substituents. Furthermore, some of the active compounds, i.e., 2-(5,6-dibromo-1H-benzimidazol-1-yl)-1-(3,4-dichlorophenyl)ethanone (4f), 2-(4,6-dibromo-1H-benzimidazol-1-yl)-1-(2,4,6-trichlorophenyl)ethanone (5g), and 2-(4,6-dibromo-1H-benzimidazol-1-yl)-1-(2,4,6-trifluorophenyl)ethanone (5j) demonstrated pro-apoptotic properties against leukemic cells with derivative 5g being the most effective.
Collapse
|
2
|
Fluconazole-Like Compounds as Potential Antifungal Agents: QSAR, Molecular Docking, and Molecular Dynamics Simulation. J CHEM-NY 2022. [DOI: 10.1155/2022/5031577] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
Today, fungal infection has become more common disease especially in some cases, such as AIDS, cancer, and organ transplant which the immune system is suppressed. On the other hand, due to the increasing resistance to current antifungal drugs, more and more options for design of novel more efficient compounds with higher resistance are needed. In this study, a series of a fluconazole analogues were subjected to quantitative structure-activity relationship analysis to find the structure requirements for modeling adequate candidate. The best multiple linear regression equation was achieved from GA-PLS and MLR modeling. Subsequently, in silico screening study was applied to found new potent lead compounds based on the resulted model. The ability of the best designed compounds for antifungal activity was investigated by using molecular dynamic (MD) and molecular docking simulation. The results showed that compound F13 can efficiently bind to lanestrol 14-α demethylase target similar to other antifungal azoles. The molecular docking studies revealed an interesting binding profile with very high receptor affinity to the CYP51 active site. The triazole moiety of ligand F13 pointed to HEM group in lanestrol 14-α demethylase site and coordinated to Fe of HEM through its N4 atom. Also, there was a convenient relevance between QSAR and docking results. With the compound F13 which demonstrated the most promising minimum inhibitory concentration (MIC) values, it can be concluded that F13 is appropriate candidate for the development as antifungal agent.
Collapse
|
3
|
Liao J, Liao G, Gao Y, Chai X, Wu Q, Zhao Q. Synthesis and Biological Activities of Diosgenin-Triazole Conjugates with a 1,3-Dipolar Cycloaddition Reaction. Chem Nat Compd 2021. [DOI: 10.1007/s10600-021-03552-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
4
|
Tratrat C. 1,2,4-Triazole: A Privileged Scaffold for the Development of Potent Antifungal Agents - A Brief Review. Curr Top Med Chem 2021; 20:2235-2258. [PMID: 32621720 DOI: 10.2174/1568026620666200704140107] [Citation(s) in RCA: 21] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/19/2020] [Revised: 03/04/2020] [Accepted: 04/13/2020] [Indexed: 12/23/2022]
Abstract
Over the past decades, a tremendous rise in invasive fungal infection diseases attributed to the yeast Candida albicans in immunocompromised individuals poses a seriously challenging issue. Another concern is the emergence of multi-drug resistant pathogens to the existing medicines due to their overuse and misuse. It was recently reported that 25-55% of the mortality rate is caused by invasive infection. Despite a large variety of drugs being available to treat invasive candidiasis, only two of them contain a 1,2,4-triazole core, namely Fluconazole and itraconazole, which are efficient in treating infection induced by fungal Candida species. Moreover, long-term therapy associated with azole medications has led to an increase in azole resistance as well as a high risk of toxicity. Despite numerous outstanding achievements in antifungal drug discovery, development of novel, safer and potent antifungal agents while overcoming the resistance problem associated with the current drugs is becoming the main focus of medicinal chemists. Therefore, this review outlines the breakthroughs in medicinal chemistry research regarding 1,2,4- triazole-based derivatives as potential antifungal agents in the past decade. In addition, the structureactivity relationship of these compounds is also discussed.
Collapse
Affiliation(s)
- Christophe Tratrat
- Department of Pharmaceutical Sciences, College of Clinical Pharmacy, King Faisal University, Al-Ahsa 31982, Saudi Arabia
| |
Collapse
|
5
|
Pachuta-Stec A. Antioxidant Activity of 1,2,4-Triazole and Its Derivatives: A Mini Review. Mini Rev Med Chem 2021; 22:1081-1094. [PMID: 33797373 DOI: 10.2174/1389557521666210401091802] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2020] [Revised: 01/29/2021] [Accepted: 02/21/2021] [Indexed: 02/01/2023]
Abstract
The information about the presence of free radicals in biological materials was given for the first time about 70 years ago. Since then, numerous scientific studies have been conducted and the science of free radicals was born. Today we know that free radicals are by-products of enzymatic reactions occurring in the organism. They are produced during endogenous processes such as: cell respiration, phagocytosis, biosynthesis, catalysis, and biotransformation. They can also be produced by exogenous processes (radiation, sunlight, heavy metals, bacteria, fungi, protozoa and viruses). The overproduction of free radicals affects the aging processes, oxidative stress (OS) and takes part in the pathogenesis of various diseases. Among them are cancer, rheumatoid arthritis, neurodegenerative diseases: Alzheimer and Parkinson, pulmonary diseases, atherosclerosis and DNA damage. Compounds with antioxidant activity are very important nowadays because they allow organisms to keep a balance between the production of free radicals and the speed of their neutralization in the body. Next to the natural antioxidants (flavonoids, carotenoids, vitamins, etc.), synthetic ones are also of great importance. Among synthetic compounds with antioxidant activity are 1,2,4-triazoles and its derivatives. 1,2,4-Triazoles are heterocyclic compounds with three nitrogen atoms. Due to a broad spectrum of biological activities, these derivatives have been of interest to scientists for many years. Some of them are also used as drugs. The finding of new synthetic compounds with antioxidant features in the triazole group has become important problem of medicinal chemistry.
Collapse
Affiliation(s)
- Anna Pachuta-Stec
- Independent Radiopharmacy Unit, Faculty of Pharmacy, Medical University of Lublin. Poland
| |
Collapse
|
6
|
Deng L, Liu Y, Zhu Y, Wan J. Transition‐Metal‐Free Annulation of Enamines and Tosyl Azide toward N‐Heterocycle Fused and 5‐Amino‐1,2,3‐Triazoles. European J Org Chem 2020. [DOI: 10.1002/ejoc.202000938] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Leiling Deng
- College of Chemistry and Chemical Engineering Jiangxi Normal University 330022 Nanchang P. R. China
| | - Yunyun Liu
- College of Chemistry and Chemical Engineering Jiangxi Normal University 330022 Nanchang P. R. China
| | - Yanping Zhu
- School of Pharmacy Key Laboratory of Molecular Pharmacology and Drug Evaluation Ministry of Education Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong Yantai University 264005 Yantai P. R. China
| | - Jie‐Ping Wan
- College of Chemistry and Chemical Engineering Jiangxi Normal University 330022 Nanchang P. R. China
| |
Collapse
|
7
|
Oyewole RO, Oyebamiji AK, Semire B. Theoretical calculations of molecular descriptors for anticancer activities of 1, 2, 3-triazole-pyrimidine derivatives against gastric cancer cell line (MGC-803): DFT, QSAR and docking approaches. Heliyon 2020; 6:e03926. [PMID: 32462084 PMCID: PMC7243141 DOI: 10.1016/j.heliyon.2020.e03926] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/09/2020] [Revised: 03/26/2020] [Accepted: 05/01/2020] [Indexed: 02/08/2023] Open
Abstract
This work used quantum chemical method via DFT to calculate molecular descriptors for the development of QSAR model to predict bioactivity (IC50- 50% inhibition concentration) of the selected 1, 2, 3-triazole-pyrimidine derivatives against receptor (human gastric cancer cell line, MGC-803). The selected molecular parameters were obtained by B3LYP/6-31G∗∗. QSAR model linked the molecular parameters of the studied compounds to their cytotoxicity and reproduced their observed bioactivities against MGC-803. The calculated IC50 tailored the observed IC50 and greater than standard compound, 5-fluorouracil, suggesting that the developed QSAR model reproduced the observed bioactivity. Statistical analyses (including R2, CV. R2 andR a 2 gave 0.950, 0.970 and 0.844 respectively) revealed a very good fitness. Molecular docking studies revealed the hydrogen bonding with the amino acid residues in the binding site, as well as ligand conformations which are essential feature for ligand-receptor interactions. Therefore, the methods used in this study are veritable tools that can be employed in pharmacological and medicinal chemistry researches in designing better drugs with improve potency.
Collapse
Affiliation(s)
- Rhoda Oyeladun Oyewole
- Department of Pure and Applied Chemistry, Faculty of Pure and Applied Sciences, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria
| | - Abel Kolawole Oyebamiji
- Department of Pure and Applied Chemistry, Faculty of Pure and Applied Sciences, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria
- Department of Basic Sciences, Adeleke University, P.M.B. 250, Ede, Osun State, Nigeria
| | - Banjo Semire
- Department of Pure and Applied Chemistry, Faculty of Pure and Applied Sciences, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria
| |
Collapse
|
8
|
Han X, Wang S, Zhang N, Ren L, Sun X, Song Y, Wang J, Xiao B. Novel Triazole Derivatives Containing Different Ester Skeleton: Design, Synthesis, Biological Evaluation and Molecular Docking. Chem Pharm Bull (Tokyo) 2019; 68:64-69. [PMID: 31708557 DOI: 10.1248/cpb.c19-00624] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Invasive fungal disease constitutes a growing health problem and development of novel antifungal drugs with high potency and selectivity are in an urgent need. In this study, a novel series of triazole derivatives containing different ester skeleton were designed and synthesized. Microdilution broth method was used to investigate antifungal activity. Significant inhibitory activity of compounds 5c, 5d, 5e, 5f, 5m and 5n was evaluated against the Candida albicans (I), Candida albicans clinical isolate (II), Candida glabrata clinical isolate (I), and Candida glabrata (II) with minimum inhibitory concentrations (MIC80) values ranging from 2 to 16 µg/mL. Notably, compounds 5e and 5n showed the best inhibition against Candida albicans (II), Candida glabrata (I), and Candida glabrata (II) at the concentrations of 2 and 8 µg/mL, respectively. Molecular docking study revealed that the target compounds interacted with CYP51 mainly through hydrophobic and van der Waals interactions. The results indicated that these novel triazole derivatives could serve as promising leads for development of antifungal agents.
Collapse
Affiliation(s)
- Xiaoyan Han
- Laboratory of Clinical Pharmacy, Ordos School of Clinical Medicine, Inner Mongolia Medical University
| | - Shumin Wang
- Laboratory of Clinical Pharmacy, Ordos School of Clinical Medicine, Inner Mongolia Medical University
| | - Na Zhang
- Laboratory of Clinical Pharmacy, Ordos School of Clinical Medicine, Inner Mongolia Medical University
| | - Liwen Ren
- Beijing Key Laboratory of Drug Target Identification, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College
| | - Xiaoyang Sun
- National Drug Clinical Trial Institution of CangZhou Central Hospital
| | - Yali Song
- Key Laboratory of Pharmaceutical Quality Control of Hebei Province, College of Pharmaceutical Sciences, Hebei University
| | - Jinhua Wang
- Beijing Key Laboratory of Drug Target Identification, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College
| | - Bin Xiao
- Laboratory of Clinical Pharmacy, Ordos School of Clinical Medicine, Inner Mongolia Medical University.,Beijing Key Laboratory of Drug Target Identification, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College
| |
Collapse
|
9
|
Su CM, Wang CH, Hou GG. Crystal structure of N
1, N
3-bis(2-hydroxyethyl)- N
1, N
1, N
3, N
3-tetramethylpropane-1,3-diaminium dibromide, C 11H 28Br 2N 2O 2. Z KRIST-NEW CRYST ST 2019. [DOI: 10.1515/ncrs-2019-0258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
C11H28Br2N2O2, triclinic, P1̄ (no. 2), a = 12.0519(11) Å, b = 12.6670(12) Å, c = 12.9161(12) Å, α = 117.088(3)°, β = 92.459(1)°, γ = 108.199(2))°, V = 1627.2(3) Å3, Z = 4, R
gt(F) = 0.0645, wR
ref(F
2) = 0.1632, T = 298(2) K.
Collapse
Affiliation(s)
- Chang-Ming Su
- School of Pharmacy, The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Binzhou Medical University , Yantai, 264003 , P.R. China
| | - Chun-Hua Wang
- School of Pharmacy, The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Binzhou Medical University , Yantai, 264003 , P.R. China
| | - Gui-Ge Hou
- School of Pharmacy, The Key Laboratory of Prescription Effect and Clinical Evaluation of State Administration of Traditional Chinese Medicine of China, Binzhou Medical University , Yantai, 264003 , P.R. China
| |
Collapse
|
10
|
Jain A, Piplani P. Exploring the Chemistry and Therapeutic Potential of Triazoles: A Comprehensive Literature Review. Mini Rev Med Chem 2019; 19:1298-1368. [DOI: 10.2174/1389557519666190312162601] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2018] [Revised: 02/28/2019] [Accepted: 03/06/2019] [Indexed: 12/20/2022]
Abstract
:
Triazole is a valuable platform in medicinal chemistry, possessing assorted pharmacological
properties, which could play a major role in the common mechanisms associated with various disorders
like cancer, infections, inflammation, convulsions, oxidative stress and neurodegeneration. Structural
modification of this scaffold could be helpful in the generation of new therapeutically useful
agents. Although research endeavors are moving towards the growth of synthetic analogs of triazole,
there is still a lot of scope to achieve drug discovery break-through in this area. Upcoming therapeutic
prospective of this moiety has captured the attention of medicinal chemists to synthesize novel triazole
derivatives. The authors amalgamated the chemistry, synthetic strategies and detailed pharmacological
activities of the triazole nucleus in the present review. Information regarding the marketed triazole derivatives
has also been incorporated. The objective of the review is to provide insights to designing and
synthesizing novel triazole derivatives with advanced and unexplored pharmacological implications.
Collapse
Affiliation(s)
- Ankit Jain
- Department of Pharmaceutical Chemistry, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh- 160014, India
| | - Poonam Piplani
- Department of Pharmaceutical Chemistry, University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh- 160014, India
| |
Collapse
|
11
|
Emami S, Ghobadi E, Saednia S, Hashemi SM. Current advances of triazole alcohols derived from fluconazole: Design, in vitro and in silico studies. Eur J Med Chem 2019; 170:173-194. [DOI: 10.1016/j.ejmech.2019.03.020] [Citation(s) in RCA: 27] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2018] [Revised: 01/13/2019] [Accepted: 03/06/2019] [Indexed: 01/05/2023]
|
12
|
Utthra PP, Raman N. Probing the potency of triazole tethered Schiff base complexes and the effect of substituents on their biological attributes. Int J Biol Macromol 2018; 116:194-207. [DOI: 10.1016/j.ijbiomac.2018.05.009] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2018] [Revised: 04/21/2018] [Accepted: 05/02/2018] [Indexed: 01/14/2023]
|
13
|
Lauder K, Toscani A, Scalacci N, Castagnolo D. Synthesis and Reactivity of Propargylamines in Organic Chemistry. Chem Rev 2017; 117:14091-14200. [PMID: 29166000 DOI: 10.1021/acs.chemrev.7b00343] [Citation(s) in RCA: 300] [Impact Index Per Article: 42.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Propargylamines are a versatile class of compounds which find broad application in many fields of chemistry. This review aims to describe the different strategies developed so far for the synthesis of propargylamines and their derivatives as well as to highlight their reactivity and use as building blocks in the synthesis of chemically relevant organic compounds. In the first part of the review, the different synthetic approaches to synthesize propargylamines, such as A3 couplings and C-H functionalization of alkynes, have been described and organized on the basis of the catalysts employed in the syntheses. Both racemic and enantioselective approaches have been reported. In the second part, an overview of the transformations of propargylamines into heterocyclic compounds such as pyrroles, pyridines, thiazoles, and oxazoles, as well as other relevant organic derivatives, is presented.
Collapse
Affiliation(s)
- Kate Lauder
- School of Cancer and Pharmaceutical Sciences, King's College London , Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Anita Toscani
- School of Cancer and Pharmaceutical Sciences, King's College London , Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Nicolò Scalacci
- School of Cancer and Pharmaceutical Sciences, King's College London , Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom
| | - Daniele Castagnolo
- School of Cancer and Pharmaceutical Sciences, King's College London , Franklin-Wilkins Building, 150 Stamford Street, London SE1 9NH, United Kingdom
| |
Collapse
|
14
|
Wu J, Ni T, Chai X, Wang T, Wang H, Chen J, Jin Y, Zhang D, Yu S, Jiang Y. Molecular docking, design, synthesis and antifungal activity study of novel triazole derivatives. Eur J Med Chem 2017; 143:1840-1846. [PMID: 29133044 DOI: 10.1016/j.ejmech.2017.10.081] [Citation(s) in RCA: 36] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2017] [Revised: 10/24/2017] [Accepted: 10/30/2017] [Indexed: 01/28/2023]
Abstract
The incidence of life-threatening fungal infections has dramatically increased for decades. In order to develop novel antifungal agents, two series of (2R,3R)-1-(1H-1,2,4-triazol-1-yl)-2-(2,4-difluorophenyl)-3-(N-substitutied)-2-butanols (3a-o, 5a-f, 8a-u), which were analogues of voriconazole, were designed, synthesized and characterized by 1H NMR, 13C NMR and HRMS. The MIC80 values showed that the target compounds 3a-o indicated better activities than fluconazole on three important fungal pathogens except for 3i. Significant activity of compounds 3d, 3k, 3n, 3m and 3o was observed on the Aspergillus fumigatus strain (MIC80 range: 1-0.125 μg/ml). Especially, compound 3k had strong activity to inhibit the growth of ten fungal pathogens. But it didn't exhibit good activity in in vivo value. Molecular docking experiments demonstrated that 3k possessed superior affinity with target enzyme by strong hydrogen bond from morpholine ring.
Collapse
Affiliation(s)
- Junqi Wu
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China; Student Bridge, Second Military Medical University, Shanghai 200433, China
| | - Tingjunhong Ni
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Xiaoyun Chai
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Ting Wang
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Hongrui Wang
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Jindong Chen
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Yongsheng Jin
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Dazhi Zhang
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China
| | - Shichong Yu
- Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
| | - Yuanying Jiang
- Center for New Drug Research, School of Pharmacy, Second Military Medical University, Shanghai 200433, China.
| |
Collapse
|
15
|
Synthesis and biological evaluation of disulfides bearing 1,2,4-triazole moiety as antiproliferative agents. Med Chem Res 2017. [DOI: 10.1007/s00044-017-2029-0] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
|
16
|
Song P, Cui F, Li N, Xin J, Ma Q, Meng X, Wang C, Cao Q, Gu Y, Ke Y, Zhang Q, Liu H. Synthesis, Cytotoxic Activity Evaluation of Novel 1,2,3-Triazole Linked Quinazoline Derivatives. CHINESE J CHEM 2017. [DOI: 10.1002/cjoc.201700005] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Affiliation(s)
- Panpan Song
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Fei Cui
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Na Li
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Jingchao Xin
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Qisheng Ma
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Xiangchuan Meng
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Chaojie Wang
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Qinpo Cao
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Yifei Gu
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Yu Ke
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Qiurong Zhang
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| | - Hongmin Liu
- School of Pharmaceutical Sciences; Zhengzhou University; Zhengzhou Henan 450001 China
- Collaborative Innovation Center of New Drug Research and Safety Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Henan Province for Drug Quality and Evaluation; Zhengzhou Henan 450001 China
- Key Laboratory of Technology of Drug Preparation (Zhengzhou University), Ministry of Education; Zhengzhou Henan 450001 China
| |
Collapse
|
17
|
Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues. Antimicrob Agents Chemother 2017; 61:AAC.00273-17. [PMID: 28607028 DOI: 10.1128/aac.00273-17] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2017] [Accepted: 05/19/2017] [Indexed: 12/30/2022] Open
Abstract
Despite recent advances in diagnostic and therapeutic methods in antifungal research, aspergillosis still remains a leading cause of morbidity and mortality. One strategy to address this problem is to enhance the activity spectrum of known antifungals, and we now report the first successful application of Candida antarctica lipase (CAL) for the preparation of optically enriched fluconazole analogues. Anti-Aspergillus activity was observed for an optically enriched derivative, (-)-S-2-(2',4'-difluorophenyl)-1-hexyl-amino-3-(1‴,2‴,4‴)triazol-1‴-yl-propan-2-ol, which exhibits MIC values of 15.6 μg/ml and 7.8 μg/disc in broth microdilution and disc diffusion assays, respectively. This compound is tolerated by mammalian erythrocytes and cell lines (A549 and U87) at concentrations of up to 1,000 μg/ml. When incorporated into dextran nanoparticles, the novel, optically enriched fluconazole analogue exhibited improved antifungal activity against Aspergillus fumigatus (MIC, 1.63 μg/ml). These results not only demonstrate the ability of biocatalytic approaches to yield novel, optically enriched fluconazole derivatives but also suggest that enantiomerically pure fluconazole derivatives, and their nanotized counterparts, exhibiting anti-Aspergillus activity may have reduced toxicity.
Collapse
|
18
|
Chen HJ, Jiang YJ, Zhang YQ, Jing QW, Liu N, Wang Y, Zhang WN, Sheng CQ. New triazole derivatives containing substituted 1,2,3-triazole side chains: Design, synthesis and antifungal activity. CHINESE CHEM LETT 2017. [DOI: 10.1016/j.cclet.2016.11.027] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
19
|
Santos TF, de Jesus JB, Neufeld PM, Jordão AK, Campos VR, Cunha AC, Castro HC, de Souza MCBV, Ferreira VF, Rodrigues CR, Abreu PA. Exploring 1,2,3-triazole derivatives by using in vitro and in silico assays to target new antifungal agents and treat Candidiasis. Med Chem Res 2017. [DOI: 10.1007/s00044-017-1789-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
20
|
Design, synthesis and antiproliferative activity studies of novel dithiocarbamate-chalcone derivates. Bioorg Med Chem Lett 2016; 26:3918-22. [PMID: 27423479 DOI: 10.1016/j.bmcl.2016.07.012] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2016] [Revised: 07/02/2016] [Accepted: 07/05/2016] [Indexed: 11/20/2022]
Abstract
A series of novel dithiocarbamate-chalcone derivates were designed, synthesized and evaluated for antiproliferative activity against three selected cancer cell lines (EC-109, SK-N-SH and MGC-803). Majority of the synthesized compounds exhibited moderate to potent activity against all the cancer cell lines assayed. Particularly, compounds II2 and II5 exhibited the excellent growth inhibition against SK-N-SH with IC50 values of 2.03μM and 2.46μM, respectively. Further mechanism studies revealed that compound II2 could obviously inhibit the proliferation of SK-N-SH cells by inducing apoptosis and arresting the cell cycle at G0/G1 phase.
Collapse
|
21
|
Narva S, Chitti S, Bala BR, Alvala M, Jain N, Kondapalli VGCS. Synthesis and biological evaluation of pyrrolo[2,3- b ]pyridine analogues as antiproliferative agents and their interaction with calf thymus DNA. Eur J Med Chem 2016; 114:220-31. [DOI: 10.1016/j.ejmech.2016.02.059] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/05/2015] [Revised: 02/23/2016] [Accepted: 02/24/2016] [Indexed: 12/11/2022]
|
22
|
Synthesis and antiproliferative evaluation of novel 1,2,4-triazole derivatives incorporating benzisoselenazolone scaffold. Bioorg Med Chem Lett 2016; 26:1279-81. [DOI: 10.1016/j.bmcl.2016.01.017] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2015] [Revised: 12/29/2015] [Accepted: 01/08/2016] [Indexed: 02/01/2023]
|
23
|
Ma LY, Pang LP, Wang B, Zhang M, Hu B, Xue DQ, Shao KP, Zhang BL, Liu Y, Zhang E, Liu HM. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents. Eur J Med Chem 2014; 86:368-80. [PMID: 25180925 DOI: 10.1016/j.ejmech.2014.08.010] [Citation(s) in RCA: 82] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/17/2014] [Revised: 08/02/2014] [Accepted: 08/04/2014] [Indexed: 12/19/2022]
Affiliation(s)
- Li-Ying Ma
- New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, Avenue Kexue, Zhengzhou 450001, PR China
| | - Lu-Ping Pang
- New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, Avenue Kexue, Zhengzhou 450001, PR China
| | - Bo Wang
- New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, Avenue Kexue, Zhengzhou 450001, PR China
| | - Miao Zhang
- New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, Avenue Kexue, Zhengzhou 450001, PR China
| | - Biao Hu
- New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, Avenue Kexue, Zhengzhou 450001, PR China
| | - Deng-Qi Xue
- New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, Avenue Kexue, Zhengzhou 450001, PR China
| | - Kun-Peng Shao
- New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, Avenue Kexue, Zhengzhou 450001, PR China
| | - Bao-Le Zhang
- New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, Avenue Kexue, Zhengzhou 450001, PR China
| | - Ying Liu
- New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, Avenue Kexue, Zhengzhou 450001, PR China
| | - En Zhang
- New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, Avenue Kexue, Zhengzhou 450001, PR China
| | - Hong-Min Liu
- New Drug Research & Development Center, School of Pharmaceutical Sciences, Zhengzhou University, No. 100, Avenue Kexue, Zhengzhou 450001, PR China.
| |
Collapse
|